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Cytosine methylation is an epigenetic modification of DNA catalyzed by DNA
methyltransferases. Cytosine methylation of mitochondrial DNA (mtDNA) is believed
to have relative underrepresentation; however, possible tissue and cell differences in
mtDNA methylation and relationships to neurodegenerative disease have not been
examined. We show by immunoblotting that DNA methyltransferase 3A (Dnmt3a) isoform
is present in pure mitochondria of adult mouse CNS, skeletal muscle, and testes,
and adult human cerebral cortex. Dnmt1 was not detected in adult mouse CNS or
skeletal muscle mitochondria but appeared bound to the outer mitochondrial membrane.
Immunofluorescence confirmed the mitochondrial localization of Dnmt3a and showed
5-methylcytosine (5mC) immunoreactivity in mitochondria of neurons and skeletal muscle
myofibers. DNA pyrosequencing of two loci (D-loop and 16S rRNA gene) and twelve
cytosine-phosphate-guanine (CpG) sites in mtDNA directly showed a tissue differential
presence of 5mC. Because mitochondria have been implicated in the pathogenesis
of amyotrophic lateral sclerosis (ALS), but the disease mechanisms are uncertain, we
evaluated mitochondrial Dnmt3a and 5mC levels in human superoxide dismutase-1 (SOD1)
transgenic mouse models of ALS. Mitochondrial Dnmt3a protein levels were reduced
significantly in skeletal muscle and spinal cord at presymptomatic or early disease.
Immunofluorescence showed that 5mC immunoreactivity was present in mitochondria
of neurons and skeletal myofibers, and 5mC immunoreactivity became aggregated in
motor neurons of ALS mice. DNA pyrosequencing revealed significant abnormalities
in 16S rRNA gene methylation in ALS mice. Immunofluorescence showed that 5mC
immunoreactivity can be sequestered into autophagosomes and that mitophagy was
increased and mitochondrial content was decreased in skeletal muscle in ALS mice. This
study reveals a tissue-preferential mitochondrial localization of Dnmt3a and presence of
cytosine methylation in mtDNA of nervous tissue and skeletal muscle and demonstrates
that mtDNAmethylation patterns andmitochondrial Dnmt3a levels are abnormal in skeletal
muscle and spinal cord of presymptomatic ALS mice, and these abnormalities occur in
parallel with loss of myofiber mitochondria.
Keywords: ALS, DNA pyrosequencing, Dnmt1, Dnmt3a, mitochondrial DNA, 5-methylcytosine, mitochondria,
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INTRODUCTION
Methylation of DNA on carbon five of cytosine (5-
methylcytosine, 5mC) in cytosine-phosphate-guanine (CpG)
dinucleotides is an epigenetic modification of DNA used by
cells to regulate nuclear gene expression (Jones and Takai, 2001;
Bird, 2002; Brenner and Fuks, 2006). Cytosine methylation
signals through 5mC-binding proteins to remodel chromatin and
downregulate gene expression. Cytosine methylation is mediated
by a family of DNA methyltransferase (Dnmt) enzymes (Cheng,
1995). Dnmt1 is the most abundant isoform in proliferating
cells and displays a preference for hemimethylated substrates
and is targeted to replication forks, acting to maintain DNA
methylation patterns during cell replication (Robertson, 2001),
and to DNA repair sites (Mortusewicz et al., 2005). Recently,
mutations in the Dnmt1 gene have been identified as a cause of
hereditary sensory and autonomic neuropathy type 1 (Klein et al.,
2011) and autosomal dominant cerebellar ataxia, deafness, and
narcolepsy (Winkelmann et al., 2012). Dnmt2 (also called tRNA
methyltransferase-1) transfers methyl groups to RNA instead of
DNA (Schaefer and Lyko, 2010; Motorin and Helm, 2011). DNA
methyltransferase 3A (Dnmt3a) and Dnmt3b function as de novo
methyltransferases because they methylate hemimethylated DNA
and also completely unmethylated DNA (Okano et al., 1999; Xie
et al., 1999). Dnmt3L functions as an essential regulatory cofactor
for Dnmt3a (Jia et al., 2007). Nuclear DNA methylation attracts
attention because it has been implicated in normal cell and
tissue development and differentiation (Geiman and Muegge,
2010) and in human diseases, including cancer (Calvanese et al.,
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2009), Rett syndrome (Amir et al., 1999), and, more recently,
neurodegenerative diseases (Chestnut et al., 2011; Klein et al.,
2011; Winkelmann et al., 2012; Martin and Wong, 2013).
Studies of mitochondrial DNA (mtDNA) cytosine methyla-
tion and the Dnmts that regulate mtDNA methylation are not as
common as studies of nuclear DNAmethylation; moreover, many
mitochondrial-basedmechanisms of disease have been implicated
in amyotrophic lateral sclerosis (ALS) (Beal, 2005; Martin, 2010,
2012; Reddy and Reddy, 2011; Panov et al., 2012; Santa-Cruz
et al., 2012), but mtDNA methylation and mitochondrial Dnmts
have not been studied in ALS. Earlier work tends to minimize
the occurrence and importance of mtDNA cytosine methyla-
tion. Some studies of cultured cells have found mtDNA cytosine
methylation in mouse fibroblastoid cells (Pollack et al., 1984)
and human fibroblasts (Shmookler Reis and Goldstein, 1983).
In the latter study, ∼2–5% of CCGG sites were fully methylated.
Other studies have found underrepresented or no mtDNA cyto-
sine methylation (Maekawa et al., 2004). However, the earlier
studies that failed to observe mtDNA cytosine methylation were
done on mitochondria isolated from blood. More recently, it has
been reported that Dnmt1 localizes to mitochondria in cultured
mouse embryonic fibroblasts and human colon carcinoma cells
(Shock et al., 2011) and that Dnmt3a localizes to mouse brain
and spinal cordmitochondria (Chestnut et al., 2011). Studies have
yet to examine comparatively mtDNA methylation in different
adult tissue types in vivo to test the hypothesis that there is tis-
sue specificity for mtDNA cytosine methylation. Moreover, the
physiological significance and potential pathophysiological rele-
vance of mtDNAmethylation in ALS merit exploration in light of
findings that Dnmt3 is localized to neuronal mitochondria and
appears to be upregulated in human ALS neurons and mouse
spinal motor neurons during their degeneration (Chestnut et al.,
2011).
In the current study, we demonstrate that Dnmt3a and 5mC
are in mitochondria of adult mouse and human tissue types that
are mostly excitable tissues (nervous and muscle) and that tissue
Dnmt3a levels are reduced and 5mC immunoreactivity accumu-
lates in skeletal muscle myofibers and spinal cord motor neurons
in mouse models of ALS. We also show directly by pyrosequenc-
ing that mtDNA from these tissues contains 5mC and that the
levels of 5mC in the 16S rRNA gene are increased in transgenic
mouse models of ALS.
MATERIALS AND METHODS
MICE
Wildtype and human superoxide dismutase-1 (hSOD1) transgenic
(tg) mice were used with approval from the institutional Animal
Care and Use Committee. For studies of normal DNMT3a and
5mC localizations and distributions, non-tg adult C57BL/6 and
SV129 mice (n = 20–25) were used at 2–6 months of age. Several
different tg mouse lines were used. One line was hemizygous for
a low copy number of hSOD1-G37R mutant allele driven by the
endogenous human promoter (line 29) derived from a founder
B6.Cg-Tg SOD1-G37R 29Dpr/J (stock # 008229, The Jackson
Laboratory, Bar Harbor, MA). Another tg mouse line (hSOD1-
wildtype) expressed normal wildtype human SOD1 gene (B6SJL-
TgN[SOD1] 2Gur, stock #002297, The Jackson Laboratory) at
high levels (copy number ∼25) driven by the endogenous human
promoter. These two tg lines thus expressed hSOD1 ubiqui-
tously in many tissues (Gurney et al., 1994; Martin et al., 2007,
2009; Gertz et al., 2012). We also used tg mice with skele-
tal muscle-restricted expression of hSOD1-G37R, -G93A, and
-wildtype variants (designated as hSOD1mus) which have been
described previously (Wong and Martin, 2010). All the lines of
hSOD1 tgmice were studied at presymptomatic or early tomiddle
stages of disease. Control mice were age-matched, non-tg litter-
mates. Mouse genotypes were identified by PCR. Mitochondrial
fractions were prepared from 5–10 mice/genotype.
PREPARATION OF CRUDE MITOCHONDRIAL FRACTIONS FROM
SKELETAL MUSCLE AND HEART
Tissue mitochondrial preparations were isolated from fresh tis-
sues with no prior freezing or fixation. For fresh tissue har-
vesting, mice were deeply anesthetized and decapitated; organs
and tissues were immediately removed, weighed, and placed in
ice-cold phosphate-buffered saline (PBS). Muscle crude mito-
chondrial fractions were obtained using amodification (Figure 1)
of a described method (Bhattacharya et al., 1991). The tissue
was finely minced using a razor. The pieces were resuspended
in 10ml/g digestion buffer (100mM sucrose, 10mM EDTA,
100mM Tris-HCl, 46mM KCl, pH 7.4) with 0.1mg/ml nagarse
(Sigma-Aldrich) and were digested at room temperature for
10–20min. The digest was placed in an equal volume of homoge-
nization buffer consisting of digestion buffer with 5mg/ml BSA
and complete protease inhibitor (Roche Diagnostics). The tis-
sue pieces were allowed to settle, the buffer was aspirated, and
the tissue was resuspended in an equal volume of homoge-
nization buffer. The tissue was homogenized using a PT 3100
Polytron (Kinematica) at 20,000 rpm on ice. The homogenate
was centrifuged at 500 g for 10min and the resulting supernatant
was removed to a fresh tube. The supernatant was then cen-
trifuged at 12,000 g for 20min. The resulting pellet was the crude
mitochondrial fraction.
PREPARATION OF CRUDE MITOCHONDRIAL FRACTION FROM TISSUES
OTHER THAN STRIATED MUSCLE
Crude mitochondrial fractions of organs were obtained using
a described method (Okado-Matsumoto and Fridovich, 2001)
with slight modifications (Figure 1). Brain, spinal cord, liver,
kidney, colon, and spleen were homogenized in nycodenz homog-
enization buffer (210mMmannitol, 70mM sucrose, 10mM Tris,
1mM EDTA, and protease inhibitor, pH 7.5) at a 1:5 (w/v) ratio
using a PT 3100 Polytron at 20,000 rpm on ice. The homogenate
was centrifuged at 1300 g for 10min and resultant supernatant
removed to a fresh tube. The supernatant was then centrifuged at
17,000 g for 10min. The resulting pellet was the crude mitochon-
drial fraction.
GENERATION OF PURE MITOCHONDRIAL FRACTION
A highly enriched mitochondrial fraction was obtained by
nycodenz (Axis-Shield) discontinuous gradient centrifugation
(Okado-Matsumoto and Fridovich, 2001). Gradients were pre-
pared by diluting 50% nycodenz solution (5mM Tris, 3mM
KCl, 0.3mM EDTA, 25 g nycodenz, pH 7.5, prepared in 50ml of
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FIGURE 1 | Schematic diagram of tissue fractionation and
experimental verification of mitochondrial enrichment and purity.
Tissues were homogenized in appropriate buffer using a PT3100
polytron. After centrifugation to remove tissue and cellular debris, a
crude mitochondrial pellet was obtained (fraction P2). The pellet was
resuspended in 25% nycodenz and a highly pure mitochondrial fraction
(fraction PM) was obtained by discontinuous gradient centrifugation.
Bottom left panel: Immunoblotting of the various fractions confirms the
pure mitochondria (PM) fraction to be highly enriched for mitochondria
(porin and CyPD), with very little or no contamination by cytoplasmic
(actin), microsomal (cytochrome P450), nuclear (lamin), and
peroxisomal/lysosomal (catalase) compartments. Bottom right panel:
Electron microscopy on PM fractions confirmed visually the very high
enrichment of mitochondria.
double-distilled water) with the appropriate volume of dilution
buffer (0.75 g NaCl, 5mM Tris, 3mM KCl, 0.3mM EDTA, pH
7.5, prepared in 100ml of double-distilled water) to obtain an
iso-osmotic solution. The crude mitochondrial fractions were
resuspended in 3ml 25% nycodenz buffer, layered onto 2.5ml
30% nycodenz buffer, and overlaid with 2.5ml 23% nycodenz
buffer. Samples were centrifuged at 52,000 g for 90min in a
swinging bucket rotor (Sorval TH641). The pure mitochondria
(PM) fraction was isolated from the 25%/30% interface. This
fraction was highly enriched in mitochondria (Figure 1, blot
inset) as demonstrated by the absence of markers for nucleus
(lamin), endoplasmic reticulum/microsomes (cytochrome P450
reductase), peroxisomes (catalase), and cytosol (actin), and the
enrichment in mitochondrial markers, including porin (voltage-
dependent anion channel, VDAC), cyclophilin D, and complex
V (Figures 1, 2A–C,G). Aliquots of freshly prepared PM samples
were fixed in 2% glutaraldehyde, embedded in plastic, and thin-
sectioned for electron microscopy (EM) to further validate the
mitochondrial purification using this approach (Figure 1).
To confirm that Dnmt protein was localized within mitochon-
dria rather than being bound to the surface of mitochondria,
proteinase K digestion of freshly isolated intact mitochondria
was performed. PBS-resuspended mitochondria were incubated
in 5mg/ml agarose-conjugated proteinase K (Sigma) for 30min
at 37◦C, and then centrifuged and washed in PBS for several cycles
to remove proteinase K.
IMMUNOBLOTTING
Tissue subcellular fractions were separated by SDS-PAGE on 4–
12% NuPage gels (Invitrogen) under denaturing and reducing
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FIGURE 2 | Dnmt3a is present in skeletal muscle and CNS mitochondria
of adult mouse and human. (A) Western blots showing that Dnmt3a, but
not Dnmt1, is present in adult mouse skeletal muscle mitochondria.
Dnmt1 was present in crude tissue fractions but was undetectable in pure
mitochondrial fractions even with prolonged overexposures as shown.
Western blot for the mitochondrial marker complex V is used to verify
mitochondrial enrichment of the fraction. Ponceau S-stained membrane is
used to show protein loading. (B) Experiments that establish that Dnmt1 is
bound to the outer surface of mitochondria. Freshly isolated intact skeletal
muscle mitochondria were treated (+) with agarose-conjugated proteinase
K to digest surface-bound proteins or were not treated with proteinase
K (−). Mitochondria were lysed and proteins were fractionated by
SDS-PAGE and western blotted for Dnmt1 using two different antibodies
that detect different amino acid (aa) domains of the protein. Protein loading
was revealed by reprobing the blots for complex V. Crude nuclear fractions
were used as a positive control. (C) Experiments that establish that
Dnmt3a is within mitochondria and not merely bound to the outer surface
of mitochondria. Freshly isolated intact skeletal muscle mitochondria were
treated with agarose-conjugated proteinase K to digest surface-bound
proteins. The efficacy of digestion is shown by the loss of desmin and
tubulin/MAP immunoreactivities in the treated samples, but Dnmt3a
immunoreactivity was not attenuated by proteinase K digestion. Protein
loading is shown by Ponceau S staining of membranes. Mitochondrial
enrichment is shown by complex V immunoreactivity. (D) Adult mouse
brain and spinal cord were homogenized, fractionated and immunoblotted
with antibody to Dnmt3a. Lanes were loaded with equivalent amounts of
protein from the crude homogenate (H) and different fractions, including
nuclear-enriched and insoluble material (P1), post-nuclear supernatant (S1),
crude mitochondria (P2), post-mitochondrial supernatant (S2), and pure
mitochondria (PM). See Figure 1 for the validation of this fractionation
method. The 100 kDa form of Dnmt3a was present in all fractions,
including the pure mitochondria, while the 78 kDa form was present in all
fractions except the mitochondria. (E) Western blot comparing the levels of
Dnmt3a and isoform specificity in skeletal muscle (100µg protein) and
spinal cord (50µg protein). Dnmt3a expression is greater in spinal cord
compared to skeletal muscle. The 78 kDa isoform predominates in skeletal
muscle while the 100 kDa isoform predominates in spinal cord. (F) Graph
showing the relative levels of Dnmt3a isoform immunoreactivity
determined by immunobloting of pure mitochondria isolated from adult
mouse skeletal muscle and spinal cord. Values are mean ± SD. The
100 kDa isoform was not detected in skeletal muscle even after long
exposures. (G) Immunoblot for Dnmt3a in pure mitochondria (PM)
fractions from different types of adult mouse tissues, human brain, and a
human cell line. The 100 kDa isoform of Dnmt3a was present in mouse
spinal cord, brain, heart, testes, and human brain cerebral cortex. Dnmt3a
immunoreactivity was low or undetectable in mouse spleen, liver, kidney,
and lung and in human embryonic kidney cells. Western blot for the
mitochondrial marker cyclophilin D is used to show protein loading.
conditions. Gels were transferred to a nitrocellulose membrane
using the Xcell surelock system (Invitrogen). The membranes
were stained with Ponceau S (Sigma) to determine transfer effi-
ciency, destained, blocked with 1% BSA/0.05% Tween 20/TBS
and incubated with primary antibodies: rabbit polyclonal anti-
cytochrome P450 reductase (Stressgen) at 1:1000; mouse mon-
oclonal anti-actin (Chemicon) at 1:1000; mouse monoclonal
anti-porin (Mitosciences) at 1:3000; rabbit polyclonal anti-lamin
(Millipore) at 1:500; sheep polyclonal anti-catalase (Biodesign
International) at 1:2000; mouse anti-cyclophilin D (Mitosciences)
at 1:3000; mouse monoclonal anti-complex V (Molecular Probes
Invitrogen) at 1:10,000; rabbit polyclonal and mouse mono-
clonal anti-Dnmt3a (Cell Signaling, Abgent, and Alexis) at 1:100–
1:500, rabbit polyclonal and mouse monoclonal anti-Dnmt1
(Bethyl, Novus, and Alexis) at 1:500–1:5000, and rabbit poly-
clonal antibody to Dnmt3b (Abcam) at 1:250. The details of
the Dnmt antibodies used are shown in Table 1. To confirm
the efficacy of proteinase K digestion of putative mitochondrial
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Table 1 | Antibodies to Dnmt isoforms screened in this study.




to aa 637–650 (central region)
Alexis (Enzo)
ALX-804-369
Good for mouse skeletal muscle
and CNS westerns
Dnmt1 Rabbit polyclonal Synthetic peptide corresponding
to aa 1–125 (N-terminus)
Novus Biologicals
NB100-264
Good for mouse skeletal muscle
and CNS westerns
Dnmt1 Rabbit polyclonal Synthetic peptide corresponding









(C-terminal epitope aa 705–908)
Alexis (Enzo)
ALX-804-370
Good for mouse skeletal muscle
and CNS westerns and
immunohistochemistry
Dnmt3a Rabbit polyclonal N-terminus of human Dnmt3a Cell Signaling Technology
2160
Suitable for mouse skeletal
muscle and CNS westerns and
immunohistochemistry
Dnmt3a Rabbit polyclonal Synthetic peptide corresponding




Suitable for mouse skeletal
muscle and CNS westerns
Dnmt3b Mouse monoclonal
52A1018
Mouse recombinant Dnmt3b Abcam
Ab13604
No detection of Dnmt3b in
skeletal muscle mitochondria
surface-tethered proteins, treated skeletal muscle mitochondria
were probed with antibodies to tubulin/microtubule associated
proteins (1:1000, Sigma) and desmin (1:5000, Sigma). Antibody
to LC3A (Cell Signaling) was used as a mitochondrial autophagy
marker. Blots were washed, incubated with secondary anti-
body (1:10,000–1:50,000), and developed using ECL (Pierce
Supersignal West Pico). The membranes were imaged using a
CCD camera and BioRad Quantity One software or were devel-
oped using X-ray film. Immunoreactivity was quantified using
ImageJ.
IMMUNOFLUORESCENCE
Age-matched non-tg and hSOD1mus-G37R, -G93A, and -
wildtype tg mice (12–15 months of age) received an anesthetic
overdose and were perfused transcardially with 4% paraformalde-
hyde. The group sizes were 3–4 mice per genotype. Spinal cord,
skeletal muscle, and testes were removed and cryoprotected
in 20% glycerol and then frozen and cut (40µm) on a sliding
microtome. Sections were permeabilized in 0.4–1% Triton-
X100/PBS, blocked in 10% normal donkey serum or goat
serum/0.1% Triton/PBS, and incubated in primary antibody
to mitochondrial markers SOD2 (1:100, Assay Design) or
complex V (1:500, Invitrogen Molecular Probes), 5mC (1:100,
Calbiochem), Dnmt3a (1:100–500, Alexis or Abgent), or the
autophagy marker LC3A (1:100, Cell Signaling). The sections
were then rinsed, incubated in secondary antibody (1:400–800)
conjugated to AlexaFluor-488 or -594, Hoechst dye counter-
stained (for nuclear visualization), and imaged on a Zeiss LSM
510 Meta confocal microscope or Zeiss Axiophot epifluorescence
microscope.
mtDNA ISOLATION AND mtDNA PYROSEQUENCING
The PM fraction was used to isolate mtDNA using a Qiaprep
Spin Miniprep kit (Qiagen) or conventional phenol-chloroform
extraction, RNase digestion, and ethanol precipitation. mtDNA
concentration and relative purity was determined by measuring
A260 and A280 and calculating the A260/A280 ratio.
Mouse mtDNA was sequenced using Pyromark Q24 (Qiagen).
DNA (2µg) was bisulfite treated using an Epitek Bisulfite
kit (Qiagen). Purified converted DNA (10 ng) was then PCR
amplified, and 25µl of product sequenced on the Pyromark
Q24 (primers and conditions supplied by Qiagen using the
Pyromark software): Locus 1 (D-loop), forward primer 5′-
GGGTTTATTAAATTTGGGGGTAGTT-3′, biotinylated reverse
primer 5′- ATAC CAAATA CATAACACCACAAT-3′, sequenc-
ing primer 5′- ATTTGGTTTTTACTTTAGGG T-3′; Locus 2
(16S rRNA gene), forward primer 5′- TGTTGGATTAGGATA
TTTTAATGGTGTAG-3′, biotinylated reverse primer 5′- CAC
CACCCTAATAACCTTCTCTA-3′, sequencing primer 5′- ATT
TTAATGGTGTAGAAGT-3′; run conditions: 95◦C 15min, 45×
(95◦C 30 s, 58◦C 30 s, 72◦C 30 s), 72◦C 5min. The data
was validated by internal controls and presented as percent
5mC/cytosine ± standard deviation (n = 3, in duplicate) with
high agreement in duplicate measures.
EM
Age-matched non-tg and hSOD1mus-G37R, -G93A, and -
wildtype tg mice (15–17 months of age) received an anesthetic
overdose and were perfused transcardially with 2% paraformalde-
hyde/2% glutaraldehyde. The group sizes were two mice per
genotype. Tissue samples of left and right biceps femoris were
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acquired from each mouse and process and embedded in plastic
for conventional transmission EM as described (Martin et al.,
1994). Tissue samples were cut in the transverse plane at 0.5µm
for high-resolution light microscopy and then thin sections were
cut and collected on copper grids for EM. These sections were
viewed and imaged using a Phillips CM12 electron microscope.
Digital electron micrographs from each mouse genotype were
used to determine subsarcolemmal mitochondrial layer thickness
and intermyofibrillar mitochondrial density in at least five images
per mouse.
HUMAN CNS TISSUE
Rapid autopsy neurologic disease-free control human brain (n =
4) cerebral cortical samples were obtained through the Human
Brain Resource Center at Johns Hopkins. These fresh samples of
frontal cortex were used to isolate mitochondria for western blot
studies of Dnmts.
STATISTICAL ANALYSIS
Western blot densitometry measurements, cytosine methyla-
tion pyrosequencing measurements, and myofiber mitochondrial
density measurements were used to determine group means and
variances and comparisons among groups were analyzed using a
one-way analysis of variance and a Newman-Keuls post-hoc test
or a Student’s t-test.
RESULTS
DNMT3A LOCALIZES TO MITOCHONDRIA
We analyzed several tissue types for the presence of Dnmts in
mitochondria. A flow diagram for the mitochondrial purifica-
tion preparation is shown (Figure 1, top), and the method was
validated by western blotting (Figure 1, lower left). The frac-
tion designated as PM was highly enriched for mitochondria,
as determined by the enrichment of porin and cyclophilin D,
and was essentially free of contamination from other subcellu-
lar organelles such as the endoplasmic reticulum (cytochrome
p450), cytosol (actin), nucleus (lamin), and microsomes (cata-
lase) (Figure 1, lower left). EM was used to show by direct visual-
ization that the PM fraction had a high content of mitochondria
(Figure 1, lower right).
We examined adult mouse skeletal muscle mitochondria for
Dnmts (Figure 2A). The purity of the mitochondrial samples was
confirmed by the enrichment of complex V (Figure 2A). Dnmt3a
had a robust presence in skeletal muscle mitochondrial fractions
(Figure 2A) and was detected with several different antibodies
to Dnmt3a that recognize N-terminal, central, and C-terminal
domains of the protein (Table 1). Dnmt1 was usually not detected
in skeletal muscle PM fractions (Figure 2A), even after prolonged
exposures and use of 3 different primary antibodies recognizing
different domains of the protein (Table 1). In some mitochon-
drial preparations of skeletal muscle, Dnmt1 was detected at
very low levels (Figure 2B) but was not present in fractions of
intact mitochondria digested with agarose-bound proteinase K
(Figures 2A,B). In contrast, Dnmt1 was highly concentrated in
crude nucleus-enriched P1 fractions (Figure 1, Top) of the same
tissue homogenates (Figures 2A,B). Dnmt3b was not detected in
skeletal muscle mitochondria (data not shown).
To determine whether Dnmt3a is present within mitochondria
or bound to the surface of mitochondria, fresh intact mitochon-
dria were digested with agarose-bound proteinase K (Figure 2C).
Tubulin, microtubule-associated proteins, and desmin are known
to be tethered to the surface of striated muscle mitochondria
(Capetanaki et al., 2007), and tubulin is known to specifi-
cally dock to VDAC (Carré et al., 2002). Proteinase K digestion
removed completely or nearly completely mitochondrial-bound
cytoskeletal proteins but did not alter the robust detection of
Dnmt3a in PM (Figure 2C). This finding demonstrates that
Dnmt3a is present within skeletal muscle mitochondria.
To confirm previous observations indicating a mitochondrial
presence of Dnmt3a in nervous tissue (Chestnut et al., 2011),
we tracked by subcellular fractionation the presence of Dnmt3a
in mouse brain and spinal cord tissue (Figure 2D). Dnmt3a was
present in nucleus-containing fractions (Figure 2D, lanes H and
P1) and cytosol-containing fractions (Figure 2D, lanes H, S1,
P2, and S2). Several isoforms of Dnmt3a have been reported
(Chen et al., 2002).We detected both the 78 and 100 kDa iso-
forms of Dnmt3a in the different fractions of brain and spinal
cord (Figure 2D). Brain and spinal cord PM fractions contained
Dnmt3a (Figure 2D), as detected with three different antibodies
to the N-terminal or central regions of Dnmt3a (Table 1). The
100 kDa isoform of Dnmt3a was concentrated in PM relative to
total homogenate (Figure 2D). We were unable to detect Dnmt1
immunoreactivity in PM of brain and spinal cord using three dif-
ferent antibodies, consistent with previous data (Chestnut et al.,
2011).
Western blotting for Dnmt3a in adult mouse skeletal mus-
cle and spinal cord in a side-by-side comparison revealed tissue
differences in isoform distribution (Figure 2E). In skeletal mus-
cle, the 78 kDa isoform predominates over the 100 kDa isoform
(Figure 2F), but in spinal cord the 100 kDa isoform predominates
(Figure 2E) and accounts for nearly 100% of the total amount of
this isoform in spinal cord mitochondria (Figure 2F).
We next tested the hypothesis that mitochondrial Dnmt3a
is tissue specific. We examined by immunoblotting the pres-
ence of Dnmt3a in highly PM isolated from several adult mouse
tissues, including spleen, liver, kidney, lung, heart, and testes
(Figure 2G). The mitochondrial fractions of brain, spinal, heart,
and testes contained the 100 kDa isoform of Dnmt3a (Figure 2G).
Mitochondrial Dnmt3a protein levels were very low or unde-
tectable in spleen, liver, kidney, and lung. The faintly detectable
mitochondrial Dnmt3a in spleen, kidney, and lung appeared as
the 78 kDa isoform (Figure 2G). To determine if the mitochon-
drial presence of Dnmt3a was mouse-specific, we prepared PM
from human cerebral cortex (frontal cortex) and cultured human
embryonic kidney (HEK) 293 cells (Figure 2G). Dnmt3a was
detected robustly in mitochondria of the human brain but not
in HEK293 cells (Figure 2G). Thus, the mitochondrial localiza-
tion of Dnmt3a occurs primarily in the mitochondria of excitable
tissues in human and mouse.
MITOCHONDRIAL DNMT3A LEVELS ARE REDUCED IN SKELETAL
MUSCLE AND SPINAL CORD OF tg MOUSE MODELS OF ALS
Abnormalities in Dnmt protein levels and DNAmethylation have
been observed in human ALS CNS tissues and in mouse and cell
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models of motor neuron degeneration (Chestnut et al., 2011).
Moreover, in human ALS skeletal muscle, marked mitochondrial
abnormalities are found (Wiedemann et al., 1998; Vielhaber et al.,
2000; Krasnianski et al., 2005; Echaniz-Laguna et al., 2006; Corti
et al., 2009), and it has been proposed that skeletal muscle dis-
ease is a driving part of the disease process in ALS (Dupuis et al.,
2006; Dobrowolny et al., 2008; Wong and Martin, 2010). We
examined the levels of Dnmt3a in skeletal muscle mitochondria
in hSOD1 tg mouse models of ALS at presymptomatic or early
symptomatic stages of disease. Compared to non-tg age matched
littermates, presymptomatic tg mice expressing mutant hSOD1-
G37R non-conditionally in most tissues showed reduced levels of
Dnmt3a in skeletal muscle mitochondria (Figures 3A,B). Tg early
symptomatic mice with skeletal muscle-restricted expression of
G37Rmutant (hSOD1mus-G37R) and G93Amutant (hSOD1mus-
G93A) also had a severe loss of skeletal muscle mitochondrial
Dnmt3a (Figures 3A,B). Mitochondrial Dnmt3a protein lev-
els were reduced modestly in hSOD1mus-wildtype tg mice but
were not changed significantly in tg mice with non-conditional
expression hSOD1-wildtype allele (Figures 3A,B). Spinal cords
of hSOD1mus-G37R, -G93A, and -wildtype tg male mice at early
stages of disease also had marked reduction in mitochondrial
Dnmt3a (Figures 3C,D). The loss of Dnmt3a was selective for
the mitochondrial compartment because Dnmt3a levels in crude
homogenates of skeletal muscle and spinal cord were unchanged
in tg mice (Figure 3E).
CELLULAR LOCALIZATION OF DNMT3A AND 5mC IN SPINAL CORD AND
SKELETAL MUSCLE AND ABERRANT PATTERNS OF
IMMUNOREACTIVITY IN hSOD1mus tg MICE
Our biochemical finding that Dnmt3a is present in excitable
tissue mitochondria required direct confirmation of a mitochon-
drial Dnmt3a localization in situ and an assessment of whether
Dnmt3a in mitochondria overlaps with a reporter molecule
for DNA methylation. We also assessed whether abnormalities
in Dnmt3a and 5mC are found in tg mouse models of ALS
since abnormalities has been found in human ALS (Chestnut
et al., 2011). We used a highly specific monoclonal antibody
to detect 5mC (Kang et al., 2006). We have done additional
characterization of the 5mC antibody (Chestnut et al., 2011).
By immunofluorescence, we visualized Dnmt3a and 5mC local-
ization within spinal cord of 2–4 months old non-tg mice
(Figure 4A). Extranuclear Dnmt3a and 5mC immunoreactivi-
ties colocalized. While Dnmt3a immunoreactivity was present
diffusely in the cytoplasm, there were distinct punctate struc-
tures positive for Dnmt3a. These cytoplasmic puncta invariably
were 5mC-positive (Figure 4A, arrows), indicating that these
structures contain methylated DNA. Consistent with expecta-
tions, 5mC immunoreactivity was also detected in the nucleus of
neurons (Figures 4B,C, red).
As the only extranuclear cellular structures known to con-
tain DNA are mitochondria, we examined spinal cord for the
presence of 5mC within mitochondria. Using immunofluores-
cence for SOD2, a mitochondrial marker that shows robust
punctate labeling in the cytoplasm (Martin et al., 2007), we
determined that mitochondria contain 5mC (Figure 4B). Not all
SOD2-positive structures were also positive for 5mC (Figure 4B,
FIGURE 3 | Dnmt3a levels are reduced in hSOD1 tg mouse models of
ALS. (A) Western blot for Dnmt3a in leg skeletal muscle mitochondria
(100µg/lane) in non-conditional tg mice expressing hSOD1-G37R or
hSOD1-wildtype constructs and conditional (muscle-restricted) tg mice
expressing hSOD1mus-G37R, -G93A, or -wildtype constructs compared to
age-matched non-tg littermates. Ponceau S staining of membrane shows
protein loading. (B) Graph showing the relative levels of Dnmt3a
immunoreactivity determined by immunoblotting of pure mitochondria
isolated from hSOD1 tg mouse leg skeletal muscle. Values are mean ± SD.
Significant differences from non-tg control are indicated by single (p < 0.05)
or double (p < 0.01) asterisks. (C) Western blot for Dnmt3a in spinal cord
mitochondria fractions (50µg/lane) in conditional (muscle-restricted) tg
mice expressing hSOD1mus-G37R, -G93A, or -wildtype constructs
compared to age-matched non-tg littermates. Ponceau S staining of
membrane shows protein loading. (D) Graph showing the relative levels of
Dnmt3a immunoreactivity in hSOD1mus tg mouse spinal cord. Values are
mean ± SD. Significant differences from non-tg control are indicated by an
asterisk (p < 0.05). The results have been replicated in at least 3 different
experiments. (E) Western blot for Dnmt3a in crude fractions of skeletal
muscle and spinal cord of conditional (muscle-restricted) tg mice expressing
hSOD1mus-G37R or -wildtype constructs compared to age-matched non-tg
littermates. Ponceau S staining of membrane shows protein loading.
arrows). The dual positive structures often appeared larger than
the SOD2-only positive mitochondria.
Some of the discreet cytoplasmic puncta that contained 5mC
appeared similar to autophagosomes (Martin et al., 1994; Kabeya
et al., 2000) or granules based on size and shape (Figure 4A).
The larger 5mC-positive bodies were not positive for the mito-
chondrial marker SOD2, while the smaller 5mC-positive bodies
did stain for SOD2 (Figure 4B), possibly indicating degradation
of mitochondria or mitochondrial marker. We next examined
the immunolocalization of 5mC and LC3A (Figure 4C). LC3A
is a marker for autophagosomes (Kabeya et al., 2000) that is
known to function in mitophagy (Wang and Klionsky, 2011).
5mC-containing, SOD2-negative bodies were positive for LC3A
Frontiers in Cellular Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 279 | 7
Wong et al. Mitochondrial Dnmt3a in ALS mice
FIGURE 4 | Cellular localizations of Dnmt3a and 5-methylcytosine
(5mC) in wildtype young adult mouse spinal cord and testes. (A) In 6–8
weeks old non-tg mice, Dnmt3a is present in the nucleus and in the
cytoplasm of neurons in spinal cord. Extranuclear cytoplasmic Dnmt3a
immunoreactivity (green) is localized diffusely and in discrete bodies
(arrows). These discrete bodies also contain 5mC (red, arrows). Hoechst
staining was used to identify cell nuclei. (B) Cytoplasmic 5mC is localized to
mitochondria in neurons. Some mitochondria, identified by SOD2
immunoreactivity (green, arrows), in spinal cord colocalize with 5mC
immunoreactivity (red, arrows). Many mitochondria also do not contain
5mC. The SOD2- and 5mC-positive bodies tend to be larger than normal
mitochondria (white arrows). (C) 5mC is present in autophagosomes.
Mouse spinal cord sections were immunostained for an autophagosome
marker LC3A (green) and 5mC (red). Extranuclear 5mC immunoreactivity
has a high colocalization with LC3A in autophagosomes (arrows). (D,E)
Immunofluorescent localization of Dnmt3a (red) and complex V (green) in
mouse testis. Cell nuclei are blue. Dnmt3a immunoreactivity (red) is
enriched in cells in the seminiferous tubules of testes. The boxed area in D
is represented at higher magnification in E which shows that Dnmt3a
immunoreactivity (red) partly colocalizes (seen as yellow-orange) with
mitochondria (green). Scale bars: 30µm (D); 15µm (E). (F)
Immunofluorescence for 5mC (red) and SOD2 (green) in mouse testes. Cell
nuclei are blue. 5mC immunoreactivity (red) partly colocalizes (seen as
yellow-orange) with mitochondria (green). Mature spermatozoa with scant
mitochondria are seen at left in seminiferous tubule lumen (L). Scale bar =
30µm.
(Figure 4C). The prominent colocalization of 5mC and LC3A
in the cytoplasm of spinal motor neurons suggests a relation-
ship between cytosine methylation of mtDNA and mitophagy
signaling.
In the mouse tissue screening for Dnmt3a protein lev-
els we saw that testes also contained relatively high levels of
Dnmt3a (Figure 2G). In seminiferous tubules, Dnmt3a and
5mC were discretely localized to mitochondria of spermatocytes
(Figures 4D,E). Interestingly, immunofluorescent signal for
mitochondria, Dnmt3a, and 5mC dissipated with maturation of
spermatocytes to spermatozoa within the seminiferous tubule
lumen (Figures 4D,E) consistent with a predominant pre-
fertilization elimination of paternal mitochondria and mtDNA
in sperm cells during their maturation, rather than a post-
fertilization mechanism (Luo et al., 2013).
Immunofluorescent assessments of Dnmt3a and 5mC were
done on skeletal muscle and spinal cord sections of hSOD1mus
tg mice to confirm biochemical findings and to put our
homogenate-based observations into a cellular localization
framework. In non-tg control mice, Dnmt3a colocalized with
complex V robustly in subsarcolemmal mitochondria and also
in intermyofibrillar mitochondria (Figure 5A), while Dnmt3a
and complex V immunoreactivity was severely attenuated in
hSOD1mus-G37R skeletal muscle myofibers (Figure 5B). In sub-
sarcolemmal mitochondria adjacent to myonuclei, Dnmt3a was
not colocalized with 5mC in non-tg controls (Figure 5C), but in
hSOD1mus tg mice, Dnmt3a and 5mC were prominently colo-
calized in apparent subsarcolemmal mitochondria (Figure 4D).
5mC immunoreativity was also seen in subsets of myofiber nuclei
(Figures 5C,D, green). In lumbar spinal cord motor neurons of
15–17months old non-tgmice, Dnmt3a was normally colocalized
with complex V in about a third of the mitochondria in motor
neuron cell bodies (Figure 5E) and, similarly, about a third of
the Dnmt3-positive cytoplasmic particles colocalized with 5mC
(Figure 5G). In hSOD1mus tg mice, complex V immunoreactiv-
ity was enriched in remaining lumbar motor neurons and Dnmt3
immunoreactivity appeared as aggregates associated with some
mitochondria (Figure 5F). The Dnmt3a-5mC colocalization in
remaining mitochondria in motor neurons of hSOD1mus tg mice
also revealed large numerous cytoplasmic aggregates containing
5mC (Figure 5H) consistent with findings in degenerating motor
neurons (Chestnut et al., 2011).
DIRECT DEMONSTRATION OF 5mC IN mtDNA
We directly identified 5mC in purified mtDNA by DNA pyrose-
quencing (Marsh, 2007) (Figures 6A,B). Two different loci of the
mitochondrial genome (D-loop and 16S rRNA gene) were inter-
rogated in bisulfite-treated mtDNA isolated from mouse brain,
liver, and testes (Figure 6A). Cytosine methylation was deter-
mined at five nucleotide sites in locus 1 and at seven nucleotide
sites in locus 2 (Figures 6A,B). Locus 1 in the D-loop had CpG
regions with 5mC content ranging from 9% (brain, position 4)
to 2% (liver, position 2) (Figure 6C). Most of the mtDNA CpG
sites in locus 1 of brain and testes had 5mC content at ∼4–6%
(Figure 6C). Liver mtDNA was generally at 4% 5mC content at
locus 1 (Figure 6C). In contrast, locus 2 in the 16S rRNA gene had
several CpG regions with 5mC content ranging from 7.5 to 18%
in brain and testes mtDNA and testes (Figure 6D). Locus 2 CpG
position 4 showed the highest 5mC content (Figures 6B,D). Liver
mtDNA generally had ∼5% 5mC content at locus 2, with the
exception of CpG position 4 where it was about 10% (Figure 6D).
ALS MICE HAVE ABERRANT mtDNA 5mC SIGNATURES
Cytosine methylation in mtDNA was assayed in skeletal mus-
cle and spinal cord of different hSOD1 tg mouse models of
ALS (Figures 7, 8). Tg mice with non-conditional expression of
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FIGURE 5 | Immunofluorescent localizations of Dnmt3a, mitochondria,
and 5-methylcytosine (5mC) in hSOD1mus tg mouse skeletal muscle
and spinal cord. (A,B) In non-tg mouse skeletal muscle (biceps femoris),
Dnmt3a (red) immunoreactivity can be found diffusely in the sarcoplasm and
associated with mitochondria (colocalization is seen as yellow) identified by
complex V immunoreactivity (green). Dnmt3a/complex V colocalization
occur prominently in subsarcolemmal mitochondria in non-tg mice (A, open
arrows) and in interfibrillar mitochondria (A, hatched arrow). In hSOD1mus
mouse hindleg skeletal muscle, Dnmt3a (red) immunoreactivity and
mitochondrial complex V immunoreactivity (green) are markedly attenuated.
Scale bars = 9µm (A), 15µm (B). (C,D). Myofiber perinuclear colocalization
of Dnmt3a and 5mC is intensified in hSOD1mus tg mice. In non-tg mouse
skeletal muscle (biceps femoris), Dnmt3a (red) immunoreactivity can be
found clustered around peripheral myonuclei (C, hatched arrows) and
generally has little colocalization with 5mC. In hSOD1musmouse skeletal
muscle Dnmt3a (red) and 5mC (green) immunoreactivities have prominent
perinuclear colocalizations (D, hatched arrows, yellow-orange). Scale bars =
20µm (C,D). (E,F) In ∼17 months old non-tg mice, Dnmt3a
immunoreactivity (red) is present in the nucleus and, more prominently, in
the cytoplasm of spinal cord motor neurons (E,G, open arrows).
Cytoplasmic Dnmt3a immunoreactivity (red) is localized in discreet particles
in motor neurons (E,G, arrows). Many of these cytoplasmic particles
colocalize (seen as yellow) with complex V immunoreactivity (E, green), and
thus are mitochondria, and with 5mC (G, green, arrow) and thus contain
methylated mtDNA. Scale bar in (E) (same for F–H) = 6µm. In age-matched
hSOD1mus tg mice, remaining spinal motor neurons (F, open arrow) show
intensified mitochondrial immunoreactivity for complex V (green) and the
Dnmt3a immunoreactivity largely is colocalized with complex V (F) and 5mC
(H) and is aggregated in the cytoplasm.
mutant-G37R and wildtype variants of hSOD1 were analyzed at
8–10 months of age (Figure 7). Generally, 5mC content was lower
in the D loop (locus 1) than in the 16S rRNA gene (locus 2)
in control mice. Within the D-loop, the CpG at site 2 had the
lowest % methylation, and sites 3 and 4 had the highest cyto-
sine methylation in skeletal muscle and spinal cord (Figure 7).
No significant differences in cytosine methylation of the D-loop
were seen in tg mice expressing mutant-G37R and wildtype vari-
ants of hSOD1 compared to non-tg mice. In the 16S rRNA gene
(locus 2), the CpG at site 4 had the highest % methylation of
all the sites sequenced (Figure 7). Cytosine methylation was sig-
nificantly increased at sites 1, 3, 4, 5, 6, and 7 in the 16S rRNA
gene of spinal cord in tg mice with non-conditional expression
of mutant-G37R (Figure 7), but no differences were detected in
cytosine methylation in the 16S rRNA gene of skeletal muscle
(Figure 7). Tg mice (16–20 months old) with skeletal muscle-
restricted expression of mutant-G37R and -G93A and wildtype
variants of hSOD1 (Figure 8) showed patterns of mtDNA cyto-
sinemethylation that were different compared to non-conditional
hSOD1 tg mice. Cytosine methylation in D-loop site 2 of spinal
cord was significantly reduced in hSOD1mus-G37R (Figure 8),
but other sites assayed for in the D-loop of spinal cord and skeletal
muscle were unchanged (Figure 8). In contrast, cytosine methy-
lation in all sites of the 16S rRNA gene of spinal cord was sig-
nificantly lower in hSOD1mus-wildtype mice compared to non-tg
mice (Figure 8), but G37Rmus and G93Amus mice did not differ
from control.
hSOD1mus tg MICE DEVELOP MITOCHONDRIAL ABNORMALITIES IN
SKELETAL MUSCLE AND SPINAL CORD
The loss of mitochondrial Dnmt3a seen in tg mouse models
of ALS could be related to changes in mitochondrial content.
Indeed, skeletal muscle complex V was reduced significantly in
hSOD1mus-G37R, -G93A, and -wildtype tg mice at middle stages
of disease compared to age-matched non-tg mice (Figure 9A).
The reduced levels of complex V in skeletal muscle were mirrored
by increases in the autophagy marker LC3A (Figure 9B). In con-
trast, complex V levels in spinal cord were significantly elevated
in hSOD1mus tg mice (Figure 9C), consistent with previous his-
tologic observations showing increased numbers of mitochondria
in motor neurons of these mice (Wong and Martin, 2010).
Mitochondrial distributions and numbers in skeletal muscle
were examined using high-resolution light and transmission elec-
tron microscopic evaluation of plastic sections. Non-tg control
mice were rich in subsarcolemmal and interfibrillar mitochon-
dria (Figures 10A,C). hSOD1mustg mice showed a loss of sub-
sarcolemmal and interfibrillar mitochondria (Figures 10B,D,E).
In putative type I fibers of non-tg mice the subsarcolemmal
mitochondrial layer thickness was ∼4µm (Figures 10C,E), but
in hSOD1mus-G37R, -G93A, and -wildtype tg mice, the sub-
sarcolemmal mitochondrial layer was significantly attenuated
(Figure 10E). Putative type II fibers in hSOD1mus tg mouse
skeletal muscle displayed a significantly reduced density of inter-
fibrillar mitochondria (Figure 10F) compared to age-matched
non-tg mice. EM additionally revealed evidence for subsarcolem-
mal and interfibrillar mitophagy (Figure 10D, upper inset), as
well as intramitochondrial rod-like inclusions (Figure 10D, lower
inset) indicative of mitochondrial myopathy (Schlattner et al.,
2006).
DISCUSSION
We demonstrate that the DNA methylating enzyme Dnmt3a is
present in mitochondria of mouse CNS, striated muscle, and
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FIGURE 6 | mtDNA contains 5-methylcytosine (5mC). (A) Schematic
of mouse mtDNA (Bibb et al., 1981) with depictions of the two
locations assayed for 5mC. The first locus is in the D-loop, involved
in mtDNA replication, and the second locus in the 16s rRNA
encoding region. The primer locations are shown in sequences
(wildtype or converted shown) with the CpG regions examined that
are boxed and numbered. (B) Representative pyrogram from
pyrosequencing of mouse brain mtDNA locus 2. The Y-axis is relative
intensity (in arbitrary units) and the X-axis is the dispensation
sequence showing the order of nucleotide addition to the reaction (E,
enzyme; S, substrate). The seven thick shaded bars indicate the CpG
positions with the degree of methylation (shown at top of bar)
calculated from the ratio of the peak heights of C and T. The single
narrow bar shows a bisulfite treatment control point where the peak
only at the T dispensation and not at the C dispensation confirms full
conversion by the bisulfite treatment. (C,D) Pyosequencing data of the
two regions of mtDNA from mouse brain, liver, and testes. Numbers
on the x-axis correspond to the CpG numbering in the sequence in
(A), and the y-axis is mtDNA 5mC content. In locus 1 the 5mC
content was highest in brain mtDNA. In locus 2 the 5mC content in
mtDNA was highest in the brain and testes, especially at position 4.
Of the 3 tissues, liver had the lowest mtDNA 5mC content.
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FIGURE 7 | 5-methylcytosine (5mC) content in two loci of skeletal
muscle mtDNA in non-conditional transgenic mouse models of ALS.
Graphs show the %5mC content at 5 CpG sites in the D-loop (left) and at
7CpG sites in the 16S rRNA gene in the skeletal muscle (top) and spinal
cord (bottom) of tg mice with expression of G37R or wildtype hSOD1
variants. Tg and non-tg control mice were 8–10 months of age. Values are
mean ± SEM derived from mtDNA isolated from three different mice per
genotype. Asterisks denote significant increase in hSOD1-G37R mice
compared to non-tg control (p < 0.05).
testes. We also find Dnmt3a in human cerebral cortex mitochon-
dria. Furthermore, the mtDNA of these tissues contains 5mC as
shown directly by DNA pyrosequencing. Dnmt3a protein lev-
els are reduced significantly at early disease in skeletal muscle
and spinal cord of tg mouse models of ALS, and these mice
also show aberrant patterns in 5mC immunoreactivity in skeletal
muscle and spinal motor neurons. Some 5mC-positive struc-
tures are sequestered into autophagosomes. The skeletal muscle
of presymptomatic tg mouse models of ALS shows accumulation
of autophagy marker, loss of subsarcolemmal and intermyofibril-
lar mitochondria, and ultrastructural evidence for mitophagy. We
conclude that mitochondrial localization of Dnmt3a and cytosine
methylation of mtDNA are tissue-preferential, mostly confined to
excitable tissues, and that regulatory mechanisms for epigenetic
modification mtDNA, or non-catalytic functions of mitochon-
drial Dnmt3a, in skeletal muscle and spinal cord are aberrant in
mouse ALS.
DNA methylating enzymes are thought traditionally to local-
ize and function in the cell nucleus where they catalyze cyto-
sine methylation leading to chromatin remodeling (Cheng, 1995;
Jones and Takai, 2001; Bird, 2002; Brenner and Fuks, 2006).
Here, we show that Dnmt3a is present the mitochondria of
adult mouse excitable tissues such as brain, spinal cord, heart,
and skeletal muscle. Mitochondrial Dnmt3a was also present in
testes. In contrast, Dnmt3a is low or undetectable in spleen,
liver, kidney, and lung. We detected mitochondrial Dnmt3a with
several different antibodies to Dnmt3a that recognize different
epitopes. The finding was not an artifact of subcellular contam-
ination because the mitochondrial preparation was assessed for
purity by immunoblotting and EM. Moreover, the Dnmt3a was
present within mitochondria rather than being docked to the
FIGURE 8 | 5-methylcytosine (5mC) content in two loci of skeletal
muscle mtDNA in conditional transgenic mouse models of ALS.
Graphs show the %5mC content at 5 CpG sites in the D-loop (left) and at 7
CpG sites in the16S rRNA gene in the skeletal muscle (top) and spinal cord
(bottom) of tg mice with skeletal muscel-restricted expression of G37R,
G93A, or wildtype hSOD1 variants. Tg and non-tg control mice were 16–20
months of age. Values are mean ± SEM derived from mtDNA isolated from
three different mice per genotype. Asterisks denote significant differences
in tg mice compared to non-tg control mice (p < 0.05).
surface of mitochondria, as was the case for the mitochondrial
association of Dnmt1. We also observed that different Dnmt3a
isoforms were enriched preferentially in different mouse tissues.
Skeletal muscle expressed primarily the 78 kDa Dnmt3a isoform,
whereas, nervous tissue expressed primarily the 100 kDa Dnmt3a
isoform. Dnmt3a was found also in mitochondria purified from
adult human cerebral cortex. Dnmt3b was not detected in mouse
skeletal muscle mitochondria (data not shown). We confirmed
the mitochondrial expression of Dnmt3a by immunolocalization.
Dnmt3a was found to colocalize with mitochondrial markers
in spinal cord, skeletal muscle and testes. Another group has
shown the presence of a Dnmt isoform associated with mito-
chondria, but the mitochondria were prepared from cell cultures
and only one antibody to Dnmt1 and one antibody putatively to
Dnmt3a was used (Shock et al., 2011). Dnmt1, but not Dnmt3a,
was found associated with mitochondria from cultured mouse
embryonic fibroblasts and human colon carcinoma cells (Shock
et al., 2011), but mitochondrial surface-associated Dnmt1 was
not ruled out by protease digestion of outer membrane-bound
proteins as done here. We did not detect Dnmt1 in mouse skele-
tal muscle mitochondria using an antibody specifically directed
to the N-terminus of Dnmt1. A commercial antibody (Abcam)
to amino acids 1–10 of the N-terminus of Dnmt1 was reportedly
used in this previous study (Shock et al., 2011), but this antibody
was not in inventory for our use. With antibodies to N-terminal
and central regions of Dnmt1, we identified here a proteinase K-
sensitive Dnmt1 in some mitochondrial preparations, indicating
surface-associated Dnmt1. Dnmt1 is associated with imprinting
mechanisms involved in maintaining methylation patterns dur-
ing cell division (Robertson, 2001), likely to be occurring in
cultured cycling cells, while Dnmt3a has de novo methylating
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FIGURE 9 | hSOD1mus tg mouse model of ALS has mitochondrial
abnormalities in skeletal muscle and spinal cord. (A) Western blot for
complex V in skeletal muscle crude extracts (100µg/lane) of early
symptomatic tg mice expressing skeletal muscle-restricted hSOD1mus-G37R
or hSOD1mus-wildtype. Ponceau S-stained membrane shows protein loading.
Graph (at right) shows the quantification of complex V immunoreactivity in
early symptomatic hSOD1mus-G37R, hSOD1mus-G93A, or
hSOD1mus-wildtype tg mice. Values (as % of control) are mean ± SD.
Asterisk denotes significant differences (p < 0.01) from non-tg control. (B)
Western blot for autophagy marker LC3A in skeletal muscle crude extracts
(100µg/lane) early symptomatic tg mice expressing skeletal
muscle-restricted hSOD1mus-G37R or hSOD1mus-wildtype. Ponceau
S-stained membrane shows protein loading. Graph (at right) shows the
quantification of LC3A immunoreactivity in early symptomatic
hSOD1mus-G37R, hSOD1mus-G93A, or hSOD1mus-wildtype tg mice. Values
(as % of control) are mean ± SD. Significant differences from non-tg control
are indicated by single (p < 0.05) or double (p < 0.01) asterisks. (C) Western
blot for complex V in spinal cord crude extracts (50µg/lane) of early
symptomatic tg mice expressing skeletal muscle-restricted hSOD1mus-G37R
or hSOD1mus-wildtype. Ponceau S-stained membrane shows protein loading.
Graph (at right) shows the quantification of complex V immunoreactivity in
spinal cord of early symptomatic hSOD1mus-G37R, hSOD1mus-G93A, or
hSOD1mus-wildtype tg mice. Values (as % of control) are mean ± SD.
Asterisk denotes significant differences (p < 0.05) from non-tg control.
activity (Okano et al., 1999). We conclude that the major mito-
chondrial Dnmt in adult mouse and human excitable tissues
in vivo is Dnmt3a.
Our finding that Dnmt3a is within mitochondria of excitable
tissue led to measurements of mtDNA methylation in these
tissues. We demonstrated directly the presence of 5mC in
mtDNA by DNA pyrosequencing (Marsh, 2007). Because
DNA pyrosequencing cannot distinguish between 5mC and 5-
hydroxymethylcytosine, our pryosequencing data represents a
measurement of 5mC and 5-hydroxymethylcytosine in mtDNA.
A recent study has also demonstrated the presence of 5mC and
5-hydroxymethylcytosine in mtDNA of cultured mouse embry-
onic fibroblasts and human colon carcinoma cells using qPCR
and Gla1 restriction enzyme digestion (Shock et al., 2011). While
it is possible the mtDNA methylation is involved in regulating
gene expression (Shock et al., 2011), as in the nucleus, the pro-
teins involved in chromatin remodeling, such as histones, are
not present in mitochondria (Spelbrink, 2010). This suggests the
intriguing possibility that cytosine methylation through Dnmt3a
is a major epigenetic mechanism involved in mitochondrial
gene regulation without partnership with histone acetylation.
Alternatively, the mtDNA methylation may serve some purpose
other than gene regulation.
Our immunolocalization experiments on mouse skeletal mus-
cle, spinal cord, and testes revealed that some 5mC-positive
structures in the cytoplasm of myofibers, spinal motor neu-
rons, and maturing spermatozoa were mitochondria because the
5mC colocalized with SOD2 or complex V and Dnmt3a. This
observation confirms a previous report of mitochondrial 5mC
localization using other mitochondrial makers (Chestnut et al.,
2011). However, some cytoplasmic 5mC-positive structures were
not positive for mitochondrial markers and had a morphol-
ogy different from mitochondria because they were larger than
typical mitochondria and sometimes appeared aggregated. We
thus sought to determine possible relationships between methy-
lated mtDNA and mitophagy and found that 5mC colocalized
with the autophagosomemarker LC3A (Klionsky and Emr, 2000).
Our findings in mouse testes suggest that enhanced mtDNA
methylation and mitophagy in maturing spermatoza in semi-
niferous tubules could be a mechanism to reduce the major
burden of paternal mtDNA transmission prior to postfertiliza-
tion autophagy (Al Rawi et al., 2011). Autophagy has also been
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FIGURE 10 | hSOD1mus tg mouse model of ALS shows loss of
mitochondria in skeletal muscle. (A,B) Toluidine blue-stained plastic
sections (0.5µm thick) of biceps femoris muscle from 15 month-old non-tg
and hSOD1mus-G37R tg mice. In non-tg mice, type I and type II fibers have
distinct appearances as evidenced by the surrounding capillary number and
subsarcolemmal and interfibrillar mitochondria density. In tg mice, type I
fibers are less prominent with apparent loss of subsarcolemmal and
interfibrillar mitochondria. Scale bar (in A, same for B) = 8µm. (C,D) Electron
micrographs showing a high density of subsarcolemmal mitochondria in
non-tg mice (C, open arrows) and prominent attenuation of the
subsarcolemmal layer in hSOD1mus tg mice (D, open arrows). Upper inset
(D) shows prominent mitophagy of subsarcolemmal mitochondria (hatched
arrows) by a myonucleus (N) in hSOD1mus-G37R tg mouse skeletal muscle.
Scale bar = 1.3µm. Lower inset (D) shows degenerating mitochondria with
round inclusions (open white arrows) or rod inclusions (hatched white arrows)
from hSOD1mus-G93A tg mouse skeletal muscle. Scale bar = 0.5µm. (E)
Graph of the thickness of type I fiber subsarcolemmal mitochondrial layers in
age-matched (∼17 months) non-tg and hSOD1mus tg mice. Values are mean
± SD. Asterisk denotes significant differences (p < 0.01) from non-tg control.
(F) Graph of type II fiber interfibrillar mitochondrial densities in age-matched
(∼17 months) non-tg and hSOD1mus tg mice. Values are mean ± SD. Asterisk
denotes significant differences (p < 0.01) from non-tg control.
associated with nervous system and muscle disease (Batlevi and
La Spada, 2011). In hSOD1 tg mice with muscle-specific expres-
sion, large 5mC-positive aggregates were observed in the cyto-
plasm of subsets of spinal motor neurons. Similar observations
have been shown in adult mouse spinal motor neurons under-
going axotomy-induced apoptosis (Chestnut et al., 2011). The
presence of Dnmt3a and 5mC within a subset of mitochondria,
many of which are associated with autophagosomes, suggests an
upstream epigenetic mechanism for mitophagy in the regulation
of normal and pathological mitochondrial dynamics.
We have found that epigenetic mechanisms involving DNA
methylation can drive motor neuron apoptosis in cell culture
and in vivo and that aberrant regulation of DNA methylation is
part of the pathobiology of human ALS (Chestnut et al., 2011).
Abnormalities in the levels and localizations of Dnmt1, Dnmt3a,
and 5mC have been found in human ALS spinal cord and motor
cortex (Chestnut et al., 2011), and mitochondrial abnormalities
in skeletal muscle, liver, spinal motor neurons, and motor cor-
tex have been reported in human ALS (Sasaki and Iwata, 1999;
Menzies et al., 2002). However, causal disease mechanisms are
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difficult to pinpoint using human postmortem tissue. We there-
fore evaluated Dnmt3a and mtDNA methylation in several tg
mouse models of ALS expressing mutant and wildtype hSOD1
either non-conditionally with global tissue expression (Gurney
et al., 1994; Martin et al., 2007, 2009; Gertz et al., 2012) or con-
ditionally with muscle-restricted expression (Wong and Martin,
2010). In skeletal muscle, mitochondrial Dnmt3a levels were
markedly reduced in most hSOD1 tg mouse lines at stages of
disease ranging from presymptomatic to mid-symptomatic. The
loss of Dnmt3a and mitochondria in skeletal muscle was corrob-
orated microscopically by immunohistochemistry. Interestingly,
spinal cord Dnmt3a was reduced in tg mice with muscle-specific
expression of hSOD1. This change is interesting because condi-
tional ablation of Dnmt3a specifically in nervous tissue causes an
age-related ALS-like phenotype in mice involving neuromuscular
junction dismantling, motor neuron loss, and shortened lifespan
(Nguyen et al., 2007). The localizations of 5mC immunoreactivity
in skeletal muscle and spinal cord were also different in non-
conditional and muscle-specific hSOD1 tg mice compared to age-
matched control mice. Skeletal muscle disease in ALS mice thus
appears to trigger retrograde transynaptic changes in epigenetic
DNA methylation machinery in spinal cord mitochondria.
Abnormalities in mtDNA cytosine methylation were detected
by pyrosequencing in mouse models of ALS. The cytosines
interrogated were in the D-loop and 16S ribosomal RNA gene
(Figure 6A). The 16S ribosomal RNA gene was more vulnerable
than the D-loop to anomalous cytosine methylation. In the 16S
ribosomal RNA gene, six cytosine sites showed increased methy-
lation in spinal cord of hSOD1-G37R mice, and one cytosine site
showed increased methylation in skeletal muscle of hSOD1mus-
G93Amice.While five cytosines in the D-loop showed differential
levels of methylation, their methylation was similar in control
and ALS mice. While the D-loop is generally thought to be a
major regulator of mitochondrial genome transcription, it is now
known that non-promoter CpG methylation within gene bodies
can regulate gene expression in the nuclear genome (Maunakea
et al., 2010). We have no direct explanation for the apparent
mismatches between mitochondrial Dnmt3a protein levels which
decrease and 5mC which increase. Recent studies have found
that Dnmt3a has demethylase activity that is stimulated by Ca2+
ions (Chen et al., 2013), so the increased cytosine methylation
could be construed as being consistent with the loss of Dnmt3a
in mitochondria.
A mechanism for the loss of skeletal muscle mitochondria
appears to be mitophagy, as evidenced by the ultrastructure of
degeneratingmitochondrial profiles and themarked upregulation
of LC3A seen by western blotting. Because numerous copies of
mtDNA reside in single mitochondrion, Dnmt3a protein levels
may be more reflective of skeletal muscle mitochondrial num-
bers, and extensively methylatedmtDNAmay bemore stable than
Dnmt3a protein in mitochondria undergoing mitophagy. Recent
evidence supports this possibility because some mtDNA can
escape autophagy and participate in local inflammatory mech-
anisms (Oka et al., 2012). Tissue inflammation is a prominent
component of the pathobiology of mouse models of ALS (Martin
et al., 2007; Chen et al., 2010; Drechsel et al., 2012) and human
ALS (McGeer and McGeer, 2002; Corcia et al., 2013).
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